<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02735174</url>
  </required_header>
  <id_info>
    <org_study_id>CIN001_AFS4</org_study_id>
    <nct_id>NCT02735174</nct_id>
  </id_info>
  <brief_title>Improving Asthma Care by Partnering With School Nurses to Bring Asthma Care Into the Inner-City Schools</brief_title>
  <acronym>AFS4</acronym>
  <official_title>Phase 4: Improving Asthma Outcomes By Facilitating Patient-Centered Care At School (Asthma-Free School)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Medical Center, Cincinnati</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Verizon Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Luther Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Children's Hospital Medical Center, Cincinnati</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to improve the partnership between Cincinnati Children's Medical Center&#xD;
      (CCHMC), Cincinnati Public Schools (CPS), and Cincinnati Health Department (CHD) to reduce&#xD;
      childhood asthma in the inner city schools of Cincinnati and CCHMC. We are calling this&#xD;
      project &quot;asthma-free schools&quot; and bringing it to neighborhoods where the incidence of asthma&#xD;
      is especially high. We have designed this study to work with school-based asthma care&#xD;
      programs. Children with high-risk asthma will be asked to participate. &quot;High-risk&quot; will be&#xD;
      defined as poorly controlled asthma, frequent school absences, and/or need for daily&#xD;
      controller asthma medications. We will use a commercially available inhaler cap sensor to&#xD;
      help track medication use and symptoms through a smartphone. The study visits will be done&#xD;
      mostly at the school using telehealth technology similar to Skype.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is part of a community health collaboration between Cincinnati Children's Hospital&#xD;
      Medical Center (CCHMC), the local public health department and designated inner city schools.&#xD;
      The purpose is to address school-based asthma care barriers and then to test the efficacy of&#xD;
      this program in a pilot study to improve asthma outcomes in 30 urban core youth.&#xD;
&#xD;
      Greater Cincinnati's geography places it at the environmentally tricky confluence of&#xD;
      low-lying smog-trapping hills, three heavily traveled interstate highways, and high rate of&#xD;
      allergen exposure. This makes it an area ripe for asthma. The overall rate of pediatric&#xD;
      asthma in Greater Cincinnati is more than twice the national average and, in some urban-core&#xD;
      neighborhoods, as high as 10 times the national rate.&#xD;
&#xD;
      Poor asthma control across the nation and locally in Cincinnati is associated with an&#xD;
      overrepresentation of children from minority groups, low-income families, and single parent&#xD;
      households who deal with economic hardship and familial strain compared to those with&#xD;
      well-controlled asthma. Data show that no more than 50% of patients keep appointments or fill&#xD;
      prescriptions, leading to continued poor asthma control and risk for future exacerbation.&#xD;
&#xD;
      This is an interventional pilot study where about 30 high-risk asthmatic participants will be&#xD;
      identified to participate and a number of interventions will be incorporated including asthma&#xD;
      specific questionnaires, use of a commercially available inhaler cap with monitoring sensor,&#xD;
      a mobile software management platform that tracks adherence of all asthma medications, mobile&#xD;
      based telehealth medical visits to assess asthma control, and mobile based telehealth&#xD;
      adherence problem-solving interventions.&#xD;
&#xD;
      This proposal is funded through a Luther Foundation and Verizon Foundation philanthropic&#xD;
      gifts.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">November 29, 2018</completion_date>
  <primary_completion_date type="Actual">November 29, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Composite Asthma Severity Index (CASI) Score</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <description>Change in composite asthma severity index score (Baseline CASI score-6 month CASI score). A positive score indicates a better outcome.&#xD;
[The CASI score has a minimum value = 0, maximum value = 20]. The rows represent the change from baseline in scores in all subjects and subsets of participants who obtained &quot;CASI &gt;=4 at baseline and &quot;CASI &lt;4&quot; at baseline.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>Single arm asthma self-management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Interventions include:&#xD;
Sensor cap system for inhalers App for SmartPhone Motivational interviews Telehealth clinic visits</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sensor cap system for inhalers</intervention_name>
    <description>All subjects will be given a commercially available inhaler cap with monitoring sensor on clinically prescribed asthma inhalers.</description>
    <arm_group_label>Single arm asthma self-management</arm_group_label>
    <other_name>Propeller</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>App for SmartPhone</intervention_name>
    <description>All subjects will be given smart phone with mobile software management platform to motivate and record medication adherence.</description>
    <arm_group_label>Single arm asthma self-management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational interviews</intervention_name>
    <description>All subjects will have motivational telehealth visits to assess adherence and promote problem-solving skills</description>
    <arm_group_label>Single arm asthma self-management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telehealth clinic visits</intervention_name>
    <description>All subjects will have asthma medical visits via telehealth technology to assess asthma control.</description>
    <arm_group_label>Single arm asthma self-management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  history of provider diagnosed asthma&#xD;
&#xD;
          -  history of uncontrolled asthma in the past 12 months as measured by two asthma control&#xD;
             Test (ACT) scores less than 20; or more than or equal to 1 emergency room visit or&#xD;
             hospitalization for asthma; or more than or equal to 2 prednisone bursts with current&#xD;
             persistent asthma as defined by National Asthma Education and Prevention Program&#xD;
             (NAEPP) guidelines&#xD;
&#xD;
          -  attendance at participating school&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  active chronic disease apart from asthma or allergic disease&#xD;
&#xD;
          -  plans to change schools during the school year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Theresa Guilbert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>February 17, 2016</study_first_submitted>
  <study_first_submitted_qc>April 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2016</study_first_posted>
  <results_first_submitted>September 1, 2020</results_first_submitted>
  <results_first_submitted_qc>September 22, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 19, 2020</results_first_posted>
  <last_update_submitted>September 22, 2020</last_update_submitted>
  <last_update_submitted_qc>September 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital Medical Center, Cincinnati</investigator_affiliation>
    <investigator_full_name>Theresa Guilbert, MD</investigator_full_name>
    <investigator_title>M.D., Professor Division of Pulmonary Medicine</investigator_title>
  </responsible_party>
  <keyword>Telehealth</keyword>
  <keyword>Sensor cap</keyword>
  <keyword>School based care</keyword>
  <keyword>Community health</keyword>
  <keyword>AsthmaTreatSmart Application</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 10, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/74/NCT02735174/Prot_SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 12, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/74/NCT02735174/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Single Arm Asthma Self-management</title>
          <description>Interventions include:&#xD;
Sensor cap system for inhalers App for SmartPhone Motivational interviews Telehealth clinic visits&#xD;
Sensor cap system for inhalers: All subjects will be given a commercially available inhaler cap with monitoring sensor on clinically prescribed asthma inhalers.&#xD;
App for SmartPhone: All subjects will be given smart phone with mobile software management platform to motivate and record medication adherence.&#xD;
Motivational interviews: All subjects will have motivational telehealth visits to assess adherence and promote problem-solving skills&#xD;
Telehealth clinic visits: All subjects will have asthma medical visits via telehealth technology to assess asthma control.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="21"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Single Arm Asthma Self-management</title>
          <description>Interventions include:&#xD;
Sensor cap system for inhalers App for SmartPhone Motivational interviews Telehealth clinic visits&#xD;
Sensor cap system for inhalers: All subjects will be given a commercially available inhaler cap with monitoring sensor on clinically prescribed asthma inhalers.&#xD;
App for SmartPhone: All subjects will be given smart phone with mobile software management platform to motivate and record medication adherence.&#xD;
Motivational interviews: All subjects will have motivational telehealth visits to assess adherence and promote problem-solving skills&#xD;
Telehealth clinic visits: All subjects will have asthma medical visits via telehealth technology to assess asthma control.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="21"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13.67" spread="2.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline CASI score</title>
          <description>Composite Asthma Severity Index (CASI) score, minimum value 0 and maximum value 20. A lower score shows improvement.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4.67" spread="3.07"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Composite Asthma Severity Index (CASI) Score</title>
        <description>Change in composite asthma severity index score (Baseline CASI score-6 month CASI score). A positive score indicates a better outcome.&#xD;
[The CASI score has a minimum value = 0, maximum value = 20]. The rows represent the change from baseline in scores in all subjects and subsets of participants who obtained &quot;CASI &gt;=4 at baseline and &quot;CASI &lt;4&quot; at baseline.</description>
        <time_frame>Baseline to 6 months</time_frame>
        <population>21 participants were analyzed for the CASI score all participants value. Participants were grouped in two categories. 11 participants with baseline CASI &gt;=4 were analyzed independently for the CASI score &gt;=4 at Baseline Value. 10 participants with baseline CASI &lt;4 were also analyzed independently for the CASI score &lt;4 at Baseline Value.</population>
        <group_list>
          <group group_id="O1">
            <title>Single Arm Asthma Self-management</title>
            <description>Interventions include:&#xD;
Sensor cap system for inhalers App for SmartPhone Motivational interviews Telehealth clinic visits&#xD;
Sensor cap system for inhalers: All subjects will be given a commercially available inhaler cap with monitoring sensor on clinically prescribed asthma inhalers.&#xD;
App for SmartPhone: All subjects will be given smart phone with mobile software management platform to motivate and record medication adherence.&#xD;
Motivational interviews: All subjects will have motivational telehealth visits to assess adherence and promote problem-solving skills&#xD;
Telehealth clinic visits: All subjects will have asthma medical visits via telehealth technology to assess asthma control.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Composite Asthma Severity Index (CASI) Score</title>
          <description>Change in composite asthma severity index score (Baseline CASI score-6 month CASI score). A positive score indicates a better outcome.&#xD;
[The CASI score has a minimum value = 0, maximum value = 20]. The rows represent the change from baseline in scores in all subjects and subsets of participants who obtained &quot;CASI &gt;=4 at baseline and &quot;CASI &lt;4&quot; at baseline.</description>
          <population>21 participants were analyzed for the CASI score all participants value. Participants were grouped in two categories. 11 participants with baseline CASI &gt;=4 were analyzed independently for the CASI score &gt;=4 at Baseline Value. 10 participants with baseline CASI &lt;4 were also analyzed independently for the CASI score &lt;4 at Baseline Value.</population>
          <units>Change in score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="21"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change in CASI score all participants</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="21"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.14" spread="2.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change in CASI score &gt;=4 at Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="11"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.4" spread="2.50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change in CASI score &lt;4 at Baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="10"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.91" spread="1.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Single Arm Asthma Self-management</title>
          <description>Interventions include:&#xD;
Sensor cap system for inhalers App for SmartPhone Motivational interviews Telehealth clinic visits&#xD;
Sensor cap system for inhalers: All subjects will be given a commercially available inhaler cap with monitoring sensor on clinically prescribed asthma inhalers.&#xD;
App for SmartPhone: All subjects will be given smart phone with mobile software management platform to motivate and record medication adherence.&#xD;
Motivational interviews: All subjects will have motivational telehealth visits to assess adherence and promote problem-solving skills&#xD;
Telehealth clinic visits: All subjects will have asthma medical visits via telehealth technology to assess asthma control.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="21"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Theresa Guilbert, MD, MS</name_or_title>
      <organization>Cincinnati Children's Hospital Medical Center</organization>
      <phone>(513) 636-6771</phone>
      <email>Theresa.Guilbert@cchmc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

